Lv1
50 积分 2022-02-15 加入
Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer
4个月前
已完结
Targeting mRNA processing as an anticancer strategy
6个月前
已完结
3'UTR heterogeneity and cancer progression
6个月前
已完结
Alternative cleavage and polyadenylation in health and disease
6个月前
已完结
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
7个月前
已完结
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
7个月前
已完结
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
8个月前
已完结
Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
8个月前
已完结
Impact of ACSL4 on the prognosis of hepatocellular carcinoma: Association with cancer-associated fibroblasts and the tumour immune microenvironment
8个月前
已完结
皖公网安备34019202002308
